CSF in Epileptic Prodromal Alzheimer's Disease: No Diagnostic Contribution but a Pathophysiological One

Objective: To study whether cerebrospinal fluid (CSF) analysis may serve as a diagnostic test for the screening of epilepsy in sporadic prodromal Alzheimer's disease (AD). Methods: A total of 29 patients with epileptic prodromal sporadic AD patients (epADs) were included and were retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Cretin, Benjamin, Bousiges, Olivier, Hautecloque, Geoffroy, Philippi, Nathalie, Blanc, Frederic, Dibitonto, Laure, Martin-Hunyadi, Catherine, Sellal, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369500/
https://www.ncbi.nlm.nih.gov/pubmed/34413819
http://dx.doi.org/10.3389/fneur.2021.623777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369500/
https://www.ncbi.nlm.nih.gov/pubmed/34413819
http://dx.doi.org/10.3389/fneur.2021.623777

Ejemplares similares